InMed to participate in Fierce Biotech webinar on Alzheimer's neuroinflammation on Nov 12, 2024

InMed Pharmaceuticals Inc.

InMed (Nasdaq: INM) announced participation in Fierce Biotech webinar on November 12, 2024.
SVP of Preclinical R&D Dr. Eric Hsu will join a panel on neuroinflammation in Alzheimer's disease.
Webinar topics include latest Alzheimer's research, therapeutic pathways, and drugs in development.
Panel includes experts from Eli Lilly, Johns Hopkins, Michigan State, and Barrow Neurological Institute.
No financial results or material business changes were disclosed in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.